September 7, 2020

Dutch Health Ingredients company Nutrileads has announced the closing of a Series B financing round of €6.5 million. The funding is provided by Icos Capital together with Goeie-Grutten and existing shareholders DSM Venturing, Oost NL, Shift Invest and Thuja. Nutrileads will use the capital to launch its the immune-enhancing ingredient Xtramune and to progress its portfolio of health ingredients.